Disclosure statements are available on the authors' profiles:
Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019J. Clin. Oncol 2020 Aug 20;38(24)2798-2811, VN Giri, KE Knudsen, WK Kelly, HH Cheng, KA Cooney, MS Cookson, W Dahut, S Weissman, HR Soule, DP Petrylak, AP Dicker, SH AlDubayan, AE Toland, CC Pritchard, CA Pettaway, MB Daly, JL Mohler, JK Parsons, PR Carroll, R Pilarski, A Blanco, A Woodson, A Rahm, ME Taplin, TJ Polascik, BT Helfand, C Hyatt, AK Morgans, F Feng, M Mullane, J Powers, R Concepcion, DW Lin, R Wender, JR Mark, A Costello, AL Burnett, O Sartor, WB Isaacs, J Xu, J Weitzel, GL Andriole, H Beltran, A Briganti, L Byrne, A Calvaresi, T Chandrasekar, DYT Chen, RB Den, A Dobi, ED Crawford, J Eastham, S Eggener, ML Freedman, M Garnick, PT Gomella, N Handley, MD Hurwitz, J Izes, RJ Karnes, C Lallas, L Languino, S Loeb, AM Lopez, KR Loughlin, G Lu-Yao, SB Malkowicz, M Mann, P Mille, MM Miner, T Morgan, J Moreno, L Mucci, RE Myers, SM Nielsen, B O'Neil, W Pinover, P Pinto, W Poage, GV Raj, TR Rebbeck, C Ryan, H Sandler, M Schiewer, EMD Scott, B Szymaniak, W Tester, EJ Trabulsi, N Vapiwala, EY Yu, C Zeigler-Johnson, LG Gomella
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.